Enoxaparin for the long-term therapy of venous thromboembolism in patients with cancer and renal insufficiency
CONCLUSIONS: Among cancer patients with severe RI, fatal PE was 5-fold more common than fatal bleeding. The recommended doses of enoxaparin in these patients should be revisited.PMID:37832588 | DOI:10.1055/a-2191-7510
Source: Thrombosis and Haemostasis - Category: Hematology Authors: Patricia Sig üenza Juan Jos é López Núñez Concepci ón Falga Tirado Covadonga G ómez-Cuervo Antoni Riera-Mestre A ída Gil-Díaz Peter Verhamme Ana Cristina Montenegro Cristina Barbagelata-L ópez Egidio Imbalzano Manuel Monreal Source Type: research
More News: Bleeding | Cancer | Cancer & Oncology | Hematology | Lovenox | Montenegro Health | Oral Cancer | Pulmonary Thromboembolism | Thrombosis